Click for best price
Pediatric Drugs Vaccines Market Size, Share 2022
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
This report contains market size and forecasts of Pediatric Drugs and Vaccines in global, including the following market information:
Global Pediatric Drugs and Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pediatric Drugs and Vaccines Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Pediatric Drugs and Vaccines companies in 2021 (%)
The global Pediatric Drugs and Vaccines market was valued at 98250 million in 2021 and is projected to reach US$ 175610 million by 2028, at a CAGR of 8.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diphtheria Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pediatric Drugs and Vaccines include Merck & Co., Inc. (USA), Abbott Laboratories (USA), Amgen, Inc. (USA), Eli Lilly and Company (USA), F. Hoffmann-La Roche Ltd (Switzerland), Genentech, Inc. (USA), GlaxoSmithKline plc. (UK), Janssen Biologics B.V. (USA) and Actelion Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pediatric Drugs and Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric Drugs and Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pediatric Drugs and Vaccines Market Segment Percentages, by Type, 2021 (%)
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Global Pediatric Drugs and Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pediatric Drugs and Vaccines Market Segment Percentages, by Application, 2021 (%)
Newborn
Infant
Child
Global Pediatric Drugs and Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pediatric Drugs and Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatric Drugs and Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pediatric Drugs and Vaccines revenues share in global market, 2021 (%)
Key companies Pediatric Drugs and Vaccines sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Pediatric Drugs and Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
| Report Attributes |
Report Details |
| Report Title |
Pediatric Drugs and Vaccines Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pediatric Drugs and Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatric Drugs and Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatric Drugs and Vaccines Overall Market Size
2.1 Global Pediatric Drugs and Vaccines Market Size: 2021 VS 2028
2.2 Global Pediatric Drugs and Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pediatric Drugs and Vaccines Sales: 2017-2028
3 Company Landscape
3.1 Top Pediatric Drugs and Vaccines Players in Global Market
3.2 Top Global Pediatric Drugs and Vaccines Companies Ranked by Revenue
3.3 Global Pediatric Drugs and Vaccines Revenue by Companies
3.4 Global Pediatric Drugs and Vaccines Sales by Companies
3.5 Global Pediatric Drugs and Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pediatric Drugs and Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pediatric Drugs and Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pediatric Drugs and Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Pediatric Drugs and Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Pediatric Drugs and Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pediatric Drugs and Vaccines Market Size Markets, 2021 & 2028
4.1.2 Diphtheria
4.1.3 Influenza
4.1.4 Hepatitis
4.1.5 Pneumococcal Diseases
4.1.6 Meningococcal Diseases
4.1.7 Mumps
4.1.8 Others
4.2 By Type - Global Pediatric Drugs and Vaccines Revenue & Forecasts
4.2.1 By Type - Global Pediatric Drugs and Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Pediatric Drugs and Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Pediatric Drugs and Vaccines Sales & Forecasts
4.3.1 By Type - Global Pediatric Drugs and Vaccines Sales, 2017-2022
4.3.2 By Type - Global Pediatric Drugs and Vaccines Sales, 2023-2028
4.3.3 By Type - Global Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Pediatric Drugs and Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Pediatric Drugs and Vaccines Market Size, 2021 & 2028
5.1.2 Newborn
5.1.3 Infant
5.1.4 Child
5.2 By Application - Global Pediatric Drugs and Vaccines Revenue & Forecasts
5.2.1 By Application - Global Pediatric Drugs and Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Pediatric Drugs and Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Pediatric Drugs and Vaccines Sales & Forecasts
5.3.1 By Application - Global Pediatric Drugs and Vaccines Sales, 2017-2022
5.3.2 By Application - Global Pediatric Drugs and Vaccines Sales, 2023-2028
5.3.3 By Application - Global Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Pediatric Drugs and Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Pediatric Drugs and Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Pediatric Drugs and Vaccines Revenue & Forecasts
6.2.1 By Region - Global Pediatric Drugs and Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Pediatric Drugs and Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Pediatric Drugs and Vaccines Sales & Forecasts
6.3.1 By Region - Global Pediatric Drugs and Vaccines Sales, 2017-2022
6.3.2 By Region - Global Pediatric Drugs and Vaccines Sales, 2023-2028
6.3.3 By Region - Global Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pediatric Drugs and Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Pediatric Drugs and Vaccines Sales, 2017-2028
6.4.3 US Pediatric Drugs and Vaccines Market Size, 2017-2028
6.4.4 Canada Pediatric Drugs and Vaccines Market Size, 2017-2028
6.4.5 Mexico Pediatric Drugs and Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pediatric Drugs and Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Pediatric Drugs and Vaccines Sales, 2017-2028
6.5.3 Germany Pediatric Drugs and Vaccines Market Size, 2017-2028
6.5.4 France Pediatric Drugs and Vaccines Market Size, 2017-2028
6.5.5 U.K. Pediatric Drugs and Vaccines Market Size, 2017-2028
6.5.6 Italy Pediatric Drugs and Vaccines Market Size, 2017-2028
6.5.7 Russia Pediatric Drugs and Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Pediatric Drugs and Vaccines Market Size, 2017-2028
6.5.9 Benelux Pediatric Drugs and Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pediatric Drugs and Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Pediatric Drugs and Vaccines Sales, 2017-2028
6.6.3 China Pediatric Drugs and Vaccines Market Size, 2017-2028
6.6.4 Japan Pediatric Drugs and Vaccines Market Size, 2017-2028
6.6.5 South Korea Pediatric Drugs and Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Pediatric Drugs and Vaccines Market Size, 2017-2028
6.6.7 India Pediatric Drugs and Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pediatric Drugs and Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Pediatric Drugs and Vaccines Sales, 2017-2028
6.7.3 Brazil Pediatric Drugs and Vaccines Market Size, 2017-2028
6.7.4 Argentina Pediatric Drugs and Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pediatric Drugs and Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pediatric Drugs and Vaccines Sales, 2017-2028
6.8.3 Turkey Pediatric Drugs and Vaccines Market Size, 2017-2028
6.8.4 Israel Pediatric Drugs and Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Pediatric Drugs and Vaccines Market Size, 2017-2028
6.8.6 UAE Pediatric Drugs and Vaccines Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Merck & Co., Inc. (USA)
7.1.1 Merck & Co., Inc. (USA) Corporate Summary
7.1.2 Merck & Co., Inc. (USA) Business Overview
7.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Major Product Offerings
7.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 Merck & Co., Inc. (USA) Key News
7.2 Abbott Laboratories (USA)
7.2.1 Abbott Laboratories (USA) Corporate Summary
7.2.2 Abbott Laboratories (USA) Business Overview
7.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Major Product Offerings
7.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Abbott Laboratories (USA) Key News
7.3 Amgen, Inc. (USA)
7.3.1 Amgen, Inc. (USA) Corporate Summary
7.3.2 Amgen, Inc. (USA) Business Overview
7.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Major Product Offerings
7.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 Amgen, Inc. (USA) Key News
7.4 Eli Lilly and Company (USA)
7.4.1 Eli Lilly and Company (USA) Corporate Summary
7.4.2 Eli Lilly and Company (USA) Business Overview
7.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Major Product Offerings
7.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 Eli Lilly and Company (USA) Key News
7.5 F. Hoffmann-La Roche Ltd (Switzerland)
7.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporate Summary
7.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
7.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Key News
7.6 Genentech, Inc. (USA)
7.6.1 Genentech, Inc. (USA) Corporate Summary
7.6.2 Genentech, Inc. (USA) Business Overview
7.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Major Product Offerings
7.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Genentech, Inc. (USA) Key News
7.7 GlaxoSmithKline plc. (UK)
7.7.1 GlaxoSmithKline plc. (UK) Corporate Summary
7.7.2 GlaxoSmithKline plc. (UK) Business Overview
7.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Major Product Offerings
7.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 GlaxoSmithKline plc. (UK) Key News
7.8 Janssen Biologics B.V. (USA)
7.8.1 Janssen Biologics B.V. (USA) Corporate Summary
7.8.2 Janssen Biologics B.V. (USA) Business Overview
7.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Major Product Offerings
7.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 Janssen Biologics B.V. (USA) Key News
7.9 Actelion Pharmaceuticals
7.9.1 Actelion Pharmaceuticals Corporate Summary
7.9.2 Actelion Pharmaceuticals Business Overview
7.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Major Product Offerings
7.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 Actelion Pharmaceuticals Key News
7.10 AstraZeneca Plc. (UK)
7.10.1 AstraZeneca Plc. (UK) Corporate Summary
7.10.2 AstraZeneca Plc. (UK) Business Overview
7.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Major Product Offerings
7.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 AstraZeneca Plc. (UK) Key News
7.11 Boehringer Ingelheim GmbH (Germany)
7.11.1 Boehringer Ingelheim GmbH (Germany) Corporate Summary
7.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Business Overview
7.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Major Product Offerings
7.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Boehringer Ingelheim GmbH (Germany) Key News
7.12 Bristol-Myers Squibb Company (USA)
7.12.1 Bristol-Myers Squibb Company (USA) Corporate Summary
7.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Business Overview
7.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Major Product Offerings
7.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.12.5 Bristol-Myers Squibb Company (USA) Key News
7.13 Allergan, Inc. (USA)
7.13.1 Allergan, Inc. (USA) Corporate Summary
7.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Business Overview
7.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Major Product Offerings
7.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.13.5 Allergan, Inc. (USA) Key News
7.14 Novartis AG (Switzerland)
7.14.1 Novartis AG (Switzerland) Corporate Summary
7.14.2 Novartis AG (Switzerland) Business Overview
7.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Major Product Offerings
7.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.14.5 Novartis AG (Switzerland) Key News
7.15 Novo Nordisk A/S (Denmark)
7.15.1 Novo Nordisk A/S (Denmark) Corporate Summary
7.15.2 Novo Nordisk A/S (Denmark) Business Overview
7.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Major Product Offerings
7.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.15.5 Novo Nordisk A/S (Denmark) Key News
7.16 Pfizer, Inc. (USA)
7.16.1 Pfizer, Inc. (USA) Corporate Summary
7.16.2 Pfizer, Inc. (USA) Business Overview
7.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Major Product Offerings
7.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.16.5 Pfizer, Inc. (USA) Key News
7.17 Sanofi S.A (France)
7.17.1 Sanofi S.A (France) Corporate Summary
7.17.2 Sanofi S.A (France) Business Overview
7.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Major Product Offerings
7.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.17.5 Sanofi S.A (France) Key News
7.18 Shionogi Inc. (USA)
7.18.1 Shionogi Inc. (USA) Corporate Summary
7.18.2 Shionogi Inc. (USA) Business Overview
7.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Major Product Offerings
7.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.18.5 Shionogi Inc. (USA) Key News
7.19 Takeda
7.19.1 Takeda Corporate Summary
7.19.2 Takeda Business Overview
7.19.3 Takeda Pediatric Drugs and Vaccines Major Product Offerings
7.19.4 Takeda Pediatric Drugs and Vaccines Sales and Revenue in Global (2017-2022)
7.19.5 Takeda Key News
8 Global Pediatric Drugs and Vaccines Production Capacity, Analysis
8.1 Global Pediatric Drugs and Vaccines Production Capacity, 2017-2028
8.2 Pediatric Drugs and Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Pediatric Drugs and Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pediatric Drugs and Vaccines Supply Chain Analysis
10.1 Pediatric Drugs and Vaccines Industry Value Chain
10.2 Pediatric Drugs and Vaccines Upstream Market
10.3 Pediatric Drugs and Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pediatric Drugs and Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pediatric Drugs and Vaccines in Global Market
Table 2. Top Pediatric Drugs and Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pediatric Drugs and Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pediatric Drugs and Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Pediatric Drugs and Vaccines Sales by Companies, (Kg), 2017-2022
Table 6. Global Pediatric Drugs and Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pediatric Drugs and Vaccines Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Pediatric Drugs and Vaccines Product Type
Table 9. List of Global Tier 1 Pediatric Drugs and Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric Drugs and Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pediatric Drugs and Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pediatric Drugs and Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pediatric Drugs and Vaccines Sales (Kg), 2017-2022
Table 15. By Type - Global Pediatric Drugs and Vaccines Sales (Kg), 2023-2028
Table 16. By Application ? Global Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pediatric Drugs and Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pediatric Drugs and Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pediatric Drugs and Vaccines Sales (Kg), 2017-2022
Table 20. By Application - Global Pediatric Drugs and Vaccines Sales (Kg), 2023-2028
Table 21. By Region ? Global Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pediatric Drugs and Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pediatric Drugs and Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pediatric Drugs and Vaccines Sales (Kg), 2017-2022
Table 25. By Region - Global Pediatric Drugs and Vaccines Sales (Kg), 2023-2028
Table 26. By Country - North America Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pediatric Drugs and Vaccines Sales, (Kg), 2017-2022
Table 29. By Country - North America Pediatric Drugs and Vaccines Sales, (Kg), 2023-2028
Table 30. By Country - Europe Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pediatric Drugs and Vaccines Sales, (Kg), 2017-2022
Table 33. By Country - Europe Pediatric Drugs and Vaccines Sales, (Kg), 2023-2028
Table 34. By Region - Asia Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pediatric Drugs and Vaccines Sales, (Kg), 2017-2022
Table 37. By Region - Asia Pediatric Drugs and Vaccines Sales, (Kg), 2023-2028
Table 38. By Country - South America Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pediatric Drugs and Vaccines Sales, (Kg), 2017-2022
Table 41. By Country - South America Pediatric Drugs and Vaccines Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pediatric Drugs and Vaccines Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Pediatric Drugs and Vaccines Sales, (Kg), 2023-2028
Table 46. Merck & Co., Inc. (USA) Corporate Summary
Table 47. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Offerings
Table 48. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. Abbott Laboratories (USA) Corporate Summary
Table 50. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Offerings
Table 51. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Amgen, Inc. (USA) Corporate Summary
Table 53. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Offerings
Table 54. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Eli Lilly and Company (USA) Corporate Summary
Table 56. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Offerings
Table 57. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. F. Hoffmann-La Roche Ltd (Switzerland) Corporate Summary
Table 59. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Offerings
Table 60. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. Genentech, Inc. (USA) Corporate Summary
Table 62. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Offerings
Table 63. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. GlaxoSmithKline plc. (UK) Corporate Summary
Table 65. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Offerings
Table 66. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. Janssen Biologics B.V. (USA) Corporate Summary
Table 68. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Offerings
Table 69. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Actelion Pharmaceuticals Corporate Summary
Table 71. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Offerings
Table 72. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 73. AstraZeneca Plc. (UK) Corporate Summary
Table 74. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Offerings
Table 75. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 76. Boehringer Ingelheim GmbH (Germany) Corporate Summary
Table 77. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Offerings
Table 78. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 79. Bristol-Myers Squibb Company (USA) Corporate Summary
Table 80. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Offerings
Table 81. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 82. Allergan, Inc. (USA) Corporate Summary
Table 83. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Offerings
Table 84. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 85. Novartis AG (Switzerland) Corporate Summary
Table 86. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Offerings
Table 87. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 88. Novo Nordisk A/S (Denmark) Corporate Summary
Table 89. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Offerings
Table 90. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 91. Pfizer, Inc. (USA) Corporate Summary
Table 92. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Offerings
Table 93. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 94. Sanofi S.A (France) Corporate Summary
Table 95. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Offerings
Table 96. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 97. Shionogi Inc. (USA) Corporate Summary
Table 98. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Offerings
Table 99. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 100. Takeda Corporate Summary
Table 101. Takeda Pediatric Drugs and Vaccines Product Offerings
Table 102. Takeda Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 103. Pediatric Drugs and Vaccines Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 104. Global Pediatric Drugs and Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Pediatric Drugs and Vaccines Production by Region, 2017-2022 (Kg)
Table 106. Global Pediatric Drugs and Vaccines Production by Region, 2023-2028 (Kg)
Table 107. Pediatric Drugs and Vaccines Market Opportunities & Trends in Global Market
Table 108. Pediatric Drugs and Vaccines Market Drivers in Global Market
Table 109. Pediatric Drugs and Vaccines Market Restraints in Global Market
Table 110. Pediatric Drugs and Vaccines Raw Materials
Table 111. Pediatric Drugs and Vaccines Raw Materials Suppliers in Global Market
Table 112. Typical Pediatric Drugs and Vaccines Downstream
Table 113. Pediatric Drugs and Vaccines Downstream Clients in Global Market
Table 114. Pediatric Drugs and Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pediatric Drugs and Vaccines Segment by Type
Figure 2. Pediatric Drugs and Vaccines Segment by Application
Figure 3. Global Pediatric Drugs and Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pediatric Drugs and Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pediatric Drugs and Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Pediatric Drugs and Vaccines Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Pediatric Drugs and Vaccines Revenue in 2021
Figure 9. By Type - Global Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pediatric Drugs and Vaccines Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pediatric Drugs and Vaccines Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
Figure 19. US Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
Figure 33. China Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pediatric Drugs and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pediatric Drugs and Vaccines Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Pediatric Drugs and Vaccines by Region, 2021 VS 2028
Figure 50. Pediatric Drugs and Vaccines Industry Value Chain
Figure 51. Marketing Channels
